Dr. Mruthyunjaya is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000Fax+1 650-565-8297
Summary
- Prithvi Mruthyunjaya MD, MHS is Associate Professor of Ophthalmology at Stanford Univeristy, member of the Vitreoretinal Surgery Service and is the new Director of Ocular Oncology at the Byers Eye Institute. At the Duke Eye Center in Durham, NC, he finished his Ophthalmology residency, Chief Residency, and clinical-research fellowships in Vitreoretinal surgery followed by an Ocular Oncology fellowship at the Moorfields Eye Hosptial in London, UK. He has been recognized by the Heed, AOS-Knapp and Ronald G Michels foundations. He was on faculty at Duke from 2005-16 where developed an integrated Retina-Ocular Oncology program and was named a tenured Associate Professor of Ophthalmology and Radiation Oncology, Medical Director and Director of Ocular Oncology.
Dr. Mruthyunjaya’s clinical interest lies in the multi-disciplinary, vitreoretinal approach to ocular tumors and simulating conditions, and complex vitreoretinal disorders.. He manages both adult and pediatric ocular cancers with a focus on novel therapeutics, intraocular biopsy, and vision-saving strategies to reduce treatment toxicity. His academic contributions were recognized by the American Society of Retina Specialists with a Senior Honor Award. His passion lies in developing collaborative research networks and training the next generation of vitreoretinal surgeons.
Education & Training
- Duke University HospitalResidency, Ophthalmology, 1997 - 2000
- University of RochesterInternship, Internal Medicine, 1996 - 1997
- Albany Medical CollegeClass of 1996
Certifications & Licensure
- CA State Medical License 2016 - 2026
- NC State Medical License 1997 - 2025
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- An Unusual Pigmented Lesion.Shambhawi Thakur, Lucie Y Guo, Prithvi Mruthyunjaya
Ophthalmology. 2025-01-01 - Association between Obstructive Sleep Apnea and Age-related Macular Degeneration Development and Progression.Ahmed M Alshaikhsalama, Amer F Alsoudi, Karen M Wai, Euna Koo, Prithvi Mruthyunjaya
Ophthalmology. Retina. 2024-12-09 - Use of Artificial Intelligence-Based Detection of Diabetic Retinopathy in the US.Shreya A Shah, Jared T Sokol, Karen M Wai, Ehsan Rahimy, David Myung
JAMA Ophthalmology. 2024-12-01
Journal Articles
- Do Racial/Ethnic Disparities in Rates of Enucleation for Uveal Melanoma Indicate Poor Quality of Care or Financial Obstacles?—ReplyPrithvi Mruthyunjaya, MD, JAMA Ophthalmology
- Questions on Rhegmatogenous Retinal Detachment and the Day of the Week of Repair or Diagnosis—ReplyPrithvi Mruthyunjaya, MD, JAMA Ophthalmology
- Comparison of Optical Coherence Tomography with Fundus Photographs, Fluorescein Angiography, and Histopathologic Analysis in Assessing Coats DiseasePrithvi Mruthyunjaya, Cynthia A Toth, Sally S Ong, Lejla Vajzovic, JAMA
Press Mentions
- Aura Biosciences Reports Third Quarter 2024 Financial Results and Business HighlightsNovember 12th, 2024
- Stanford University Study Finds Ovarian Cancer Drug Can Affect the EyesOctober 23rd, 2024
- Rare Eye Cancer Is the Focus of 'Lookin' for a Cure' 5K RunMay 17th, 2019
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: